CGON position history
The shares of CG Oncology (CGON) that Avidity Partners Management LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 1,454,765 shares, $64M, 2.1% of portfolio, New
- 2024 Q2: 1,296,225 shares, $41M, 1.7% of portfolio, Reduce −10.9%
- 2024 Q3: 1,656,000 shares, $62M, 3.2% of portfolio, Add +27.8%
- 2024 Q4: 1,097,800 shares, $31M, 3.1% of portfolio, Reduce −33.7%
- 2025 Q1: 980,942 shares, $24M, 4.6% of portfolio, Reduce −10.6%
- 2025 Q2: 1,499,942 shares, $39M, 7.8% of portfolio, Add +52.9%
- 2025 Q3: 1,600,899 shares, $64M, 14.7% of portfolio, Add +6.7%
- 2025 Q4: 1,472,699 shares, $61M, 17.6% of portfolio, Reduce −8.0%
- 2026 Q1: 1,288,948 shares, $87M, Reduce −12.5%
- 2026 Q2: 1,398,948 shares, $99M, 15.9% of portfolio, Add +8.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|